Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box–Behnken design approach
Source abstract
Abstract
Objective: The aim of the present study was to develop and optimize topically applied nimesulide-loaded nanostructured lipid carriers. Materials and methods: Box–Behnken experimental design was applied for optimization of nanostructured lipid carriers. The independent variables were ratio of stearic acid: oleic acid (X1), poloxamer 188 concentration (X2) and lecithin concentration (X3) while particle size (Y1) and entrapment efficiency (Y2) were the chosen responses. Further, skin penetration study, in vitro release, confocal laser scanning microscopy and stability study were also performed. Results and discussion: The optimized nanostructured lipid carriers of nimesulide provide reasonable particle size, flux, and entrapment efficiency. Optimized formulation (F9) with mean particle size of 214.4 ± 11 nm showed 89.4 ± 3.40% entrapment efficiency and achieved mean flux 2.66 ± 0.09 μg/cm2/h. In vitro release study showed prolonged drug release from the optimized formulation following Higuchi release kinetics with R2 value of 0.984. Confocal laser scanning microscopy revealed an enhanced penetration of Rhodamine B-loaded nanostructured lipid carriers to the deeper layers of the skin. The stability study confirmed that the optimized formulation was considerably stable at refrigerator temperature as compared to room temperature. Conclusion: Our results concluded that nanostructured lipid carriers are an efficient carrier for topical delivery of nimesulide.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Advanced Drug Delivery Systems · Polydiacetylene-based materials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard (Hamdard University), New Delhi, India;
Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;
Glocal School of Pharmacy, Glocal University, Saharanpur, Uttar Pradesh, India
References (42)
Show source-provided references
1. 10.2174/15672011179447990710.2174/156720111794479907 ↗
2. 10.3109/03639045.2010.53221910.3109/03639045.2010.532219 ↗
3. 10.1016/j.ijbiomac.2014.03.01110.1016/j.ijbiomac.2014.03.011 ↗
4. 10.1016/j.ijpharm.2007.03.03110.1016/j.ijpharm.2007.03.031 ↗
5. 10.1016/S0168-3659(02)00368-110.1016/S0168-3659(02)00368-1 ↗
6. 10.1208/s12249-012-9865-510.1208/s12249-012-9865-5 ↗
7. 10.3748/wjg.v16.i45.565110.3748/wjg.v16.i45.5651 ↗
8. 10.1016/j.jsps.2015.01.02410.1016/j.jsps.2015.01.024 ↗
9. 10.3109/09687688.2010.52220310.3109/09687688.2010.522203 ↗
10. 10.1016/j.colsurfb.2009.09.03310.1016/j.colsurfb.2009.09.033 ↗
11. 10.1002/jps.2227110.1002/jps.22271 ↗
12. 10.1002/jps.260052121010.1002/jps.2600521210 ↗
13. 10.3109/1061186X.2012.71684510.3109/1061186X.2012.716845 ↗
14. 10.3109/21691401.2014.90982210.3109/21691401.2014.909822 ↗
15. Khan SA · Latin Am J Pharm · 2011 · 30 · 119
16. 10.1016/0378-5173(83)90064-910.1016/0378-5173(83)90064-9 ↗
17. 10.1007/s00011-011-0411-910.1007/s00011-011-0411-9 ↗
18. 10.1016/j.ijpharm.2007.03.00910.1016/j.ijpharm.2007.03.009 ↗
19. 10.1016/j.colsurfa.2014.11.01510.1016/j.colsurfa.2014.11.015 ↗
20. 10.1208/s12249-013-0034-210.1208/s12249-013-0034-2 ↗
21. 10.1166/asl.2014.548710.1166/asl.2014.5487 ↗
22. Muller RH · Curr Drug Discov Technol · 2011 · 8 · 20710.2174/157016311796799062 ↗
23. Narala A · J Pharm · 2013
24. 10.1208/s12249-007-9028-210.1208/s12249-007-9028-2 ↗
25. 10.3797/scipharm.1202-1210.3797/scipharm.1202-12 ↗
26. 10.3109/21691401.2014.90982010.3109/21691401.2014.909820 ↗
27. Peppas NA. · Pharm Acta Helv · 1985 · 60 · 110
28. 10.3109/21691401.2014.95510510.3109/21691401.2014.955105 ↗
29. 10.1016/j.ejpb.2010.05.00310.1016/j.ejpb.2010.05.003 ↗
30. 10.3109/21691401.2015.103699710.3109/21691401.2015.1036997 ↗
31. Ramjith US · Int J Curr Res Chem Pharma Sci · 2015 · 2 · 76
32. Schramlova J · Folia Biol (Praha) · 1997 · 43 · 165
33. 10.3109/10837450.2012.72372110.3109/10837450.2012.723721 ↗
34. 10.2174/156720105358598510.2174/1567201053585985 ↗
35. 10.4103/0973-8398.13492110.4103/0973-8398.134921 ↗
36. Thatipamula R · Daru · 2011 · 19 · 23
37. Tichota DM · Int J Nanomedicine · 2014 · 9 · 3855
38. 10.4314/tjpr.v13i5.110.4314/tjpr.v13i5.1 ↗
39. 10.1016/j.jsps.2012.11.00510.1016/j.jsps.2012.11.005 ↗
40. 10.2174/157016381066613120223372110.2174/1570163810666131202233721 ↗
41. 10.1155/2014/20570310.1155/2014/205703 ↗
42. Zur Muhlen A · Pharmazie · 1998 · 53 · 552